Literature DB >> 32002634

Natriuretic peptides: biomarkers for atrial fibrillation management.

Alireza Sepehri Shamloo1, Andreas Bollmann2, Nikolaos Dagres2, Gerhard Hindricks2, Arash Arya2.   

Abstract

In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia. Therefore, identification of individuals at risk of AF development/recurrence or its associated complications has emerged as a hot topic in the field of cardiology. Recently, several biomarkers have been introduced to predict AF and its consequences; however, use of biomarkers in AF management has not been highly recommended by guidelines yet. While utilization of natriuretic peptides (NPs) including brain (B-type) NPs (BNPs) in heart failure management has been well established, their use in relation to AF has not been fully understood. Accordingly, this review article aimed at presenting an overview of the role of NPs in predicting AF development/recurrence as well as its complications and making suggestions for their use in management of patients with AF in clinical settings.

Entities:  

Keywords:  Atrial fibrillation; B-Type natriuretic peptide; BNP; Biomarker; NT-ProBNP; Natriuretic peptide

Mesh：

Substances：

Year:  2020        PMID： 32002634     DOI： 10.1007/s00392-020-01608-x

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


  8 in total

Review 1.  Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction.

Authors:  Dane Rucker; Jacob Joseph
Journal:  Curr Heart Fail Rep       Date:  2022-09-30

2.  Effect of Sacubitril-Valsartan on Restoration and Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation.

Authors:  Qingsong Chen; Yunlin Chen; Fang Qin; Huaan Du; Chunxia Gan; Bei Zhou; Na Wang; Mingyang Xiao; Zhenhong Ou; Wei Zhao; Ben Cui; Zengzhang Liu; Yuehui Yin
Journal:  Front Cardiovasc Med       Date:  2022-05-30

3.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

4.  Midregional pro atrial natriuretic peptide: a novel important biomarker for noise annoyance-induced cardiovascular morbidity and mortality?

Authors:  Omar Hahad; Philipp S Wild; Jürgen H Prochaska; Andreas Schulz; Karl J Lackner; Norbert Pfeiffer; Irene Schmidtmann; Matthias Michal; Manfred Beutel; Andreas Daiber; Thomas Münzel
Journal:  Clin Res Cardiol       Date:  2020-04-18       Impact factor: 5.460

5.  Continuous electrocardiography for detecting atrial fibrillation beyond 1 year after stroke in primary care.

Authors:  Louise Feldborg Lyckhage; Morten Lock Hansen; Jens Christian Toft; Susanne Lis Larsen; Bente Brendorp; Ari Mohammad Ali; Troels Wienecke
Journal:  Heart       Date:  2020-07-03       Impact factor: 5.994

6.  Not Baseline Atrial Fibrillation but New-Onset Atrial Fibrillation and the Loss of Left Atrial Function Are Essential for Predicting Poor Outcomes in Non-ischemic Cardiomyopathy.

Authors:  Mana Okune; Masakazu Yasuda; Naoko Soejima; Kazuyoshi Kakehi; Takayuki Kawamura; Takashi Kurita; Gaku Nakazawa; Yoshitaka Iwanaga
Journal:  Front Cardiovasc Med       Date:  2021-12-14

Review 7.  Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future.

Authors:  Jan Wintrich; Ingrid Kindermann; Christian Ukena; Simina Selejan; Christian Werner; Christoph Maack; Ulrich Laufs; Carsten Tschöpe; Stefan D Anker; Carolyn S P Lam; Adriaan A Voors; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2020-03-31       Impact factor: 5.460

8.  Novel insights into peptide amidation and amidating activity in the human circulation.

Authors:  Paul Kaufmann; Andreas Bergmann; Olle Melander
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.